Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04351893 · ClinicalTrials.gov registry record

Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology

A clinical trial of Microtia and Microtia-Anotia, sponsored by Seattle Children's Hospital.

Completed
Registry status
935
Enrollment target
10
Study locations

NCT04351893 is a study of Microtia and Microtia-Anotia that has completed, run by Seattle Children's Hospital. The registered enrollment target is 935 participants, below the 1,399-participant average among 4 other Microtia trials with a reported enrollment target (33% lower). The trial reports 10 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04351893, a study of Microtia and Microtia-Anotia, has completed, sponsored by Seattle Children's Hospital.

COMPLETED
Registry status
935 participants
Enrollment target
10
Study locations

Study Summary

The CAUSE study is a multicenter study, with domestic (n=4) and international (n=6) study sites. Children and young adults (ages 0-18) who have microtia and/or craniofacial microsomia and their parents are invited to participate. Children and parents are asked to provide a DNA sample (blood or saliva) and are asked to upload a few photos of their face. Parents are asked a short interview. Participants are able to participate from home or at one of four domestic sites.

Study Locations (10)

Other

  • Pontificia Universidad Javeriana - Bogotá
  • ICESI - Cali
  • Pontificia Universidad Javeriana - Cali
  • Clínica Comfamiliar Risaralda - Pereira
  • Hospital Edgardo Rebagliati Martins - Lima
  • Instituto de Genética Médica y Molecular (INGEMM) - Madrid

California

  • Children's Hospital Los Angeles - Los Angeles

North Carolina

  • University of North Carolina - Chapel Hill

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Washington

  • Seattle Children's Hospital - Seattle

Trial Details

FieldValue
Enrollment Target 935 participants
Start Date 2018-02-23
Est. Completion 2023-08-30

Sponsor

Seattle Children's Hospital

168 total trials

What the Registry Record Tells You About NCT04351893

The ClinicalTrials.gov registry entry for NCT04351893 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 935 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,399-participant average among 4 other Microtia trials with a reported enrollment target (33% lower). The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Microtia appearing as the primary indexed condition, and to 0 interventions.

NCT04351893 reports 10 study locations spanning 5 distinct geographic areas - top geographies include Other, California, North Carolina.

Frequently Asked Questions

What is clinical trial NCT04351893 about?

NCT04351893 is a clinical study titled "Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology". The CAUSE study is a multicenter study, with domestic (n=4) and international (n=6) study sites. Children and young adults (ages 0-18) who have microtia and/or craniofacial microsomia and their parents are invited to participate. Children and parents are asked to provide a DNA sample (blood or saliv...

What is the current status of trial NCT04351893?

This trial is currently completed. The enrollment target is 935 participants. The study started on 2018-02-23. Estimated completion is 2023-08-30.

What conditions does trial NCT04351893 study?

This clinical trial studies the following conditions: Microtia, Microtia-Anotia, Craniofacial Microsomia, Hemifacial Microsomia, Goldenhar Syndrome.

Who is sponsoring clinical trial NCT04351893?

This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04351893 being conducted?

This trial has 10 study locations across California, North Carolina, Pennsylvania, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Microtia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.